cover image - Abeloff's Clinical Oncology - Elsevier eBook on VitalSource,5th Edition
ISBN: 9780323680813
Page Count: 2224
Imprint: Saunders
List Price: $349.99

Abeloff's Clinical Oncology - Elsevier eBook on VitalSource, 5th Edition

by John E. Niederhuber, MD, James O. Armitage, MD, James H Doroshow, MD, Michael B. Kastan, MD, PhD and Joel E. Tepper, MD
Elsevier eBook on VitalSource
cover image - Abeloff's Clinical Oncology - Elsevier eBook on VitalSource,5th Edition
ISBN: 9780323680813
Page Count: 2224
Imprint: Saunders
List Price: $349.99
$349.99
$279.99
Or $0.00 with a valid access code
Not Yet Available

Practical and clinically focused, Abeloff’s Clinical Oncology is a trusted medical reference book designed to capture the latest scientific discoveries and their implications for cancer diagnosis and management of cancer in the most accessible manner possible. Abeloff’s equips everyone involved - from radiologists and oncologists to surgeons and nurses - to collaborate effectively and provide the best possible cancer care.

    • Select the most appropriate tests and imaging studies for cancer diagnosis and staging of each type of cancer, and manage your patients in the most effective way possible by using all of the latest techniques and approaches in oncology.
    • Enhance your understanding of complex concepts with a color art program that highlights key points and illustrates relevant scientific and clinical problems.
    • Stay at the forefront of the latest developments in cancer pharmacology, oncology and healthcare policy, survivorship in cancer, and many other timely topics.
    • See how the most recent cancer research applies to practice through an increased emphasis on the relevance of new scientific discoveries and modalities within disease chapters.
    • Streamline clinical decision making with abundant new treatment and diagnostic algorithms as well as concrete management recommendations.
    • Take advantage of the collective wisdom of preeminent multidisciplinary experts in the field of oncology, including previous Abeloff’s editors John E. Niederhuber, James O. Armitage, and Michael B. Kastan as well as new editors James H. Doroshow from the National Cancer Institute and Joel E. Tepper of Gunderson & Tepper: Clinical Radiation Oncology.
    • Quickly and effortlessly access the key information you need with the help of an even more user-friendly, streamlined format.
    • Access the complete contents anytime, anywhere at Expert Consult, and test your mastery of the latest knowledge with 500 online multiple-choice review questions.
  • Part I: Science of Clinical Oncology

    Section A. Biology and Cancer

    1 Molecular Tools in Cancer Research

    2 Intracellular Signaling

    3 The Cellular Microenvironment and Metastases

    4 Control of the Cell Cycle

    5 Pathophysiology of Cancer Cell Death

    6 Cancer Immunology

    7 Stem Cells, Cell Differentiation, and Cancer

    8 Vascular and Interstitital Biology of Tumors

    Section B. Genesis of Cancer

    9 Environmental Factors

    10 DNA Damage Response Pathways and Cancer

    11 Viruses and Human Cancer

    12 Genetic Factors: Hereditary Cancer Predisposition Syndromes

    13 Genetic and Epigenetic Changes in Cancer

    14 Immunodeficiency and Cancer

    Section C. Diagnosing Cancer

    15 Flow Cytometry in Oncologic Diagnosis

    16 WHO Classification of Hematologic Malignancies

    17 Pathology, Biomarkers, and Molecular Diagnostics

    18 Imaging

    Section D. Preventing and Treating Cancer

    19 Biostatistics and Bioinformatics in Clinical Trials

    20 Structures Supporting Cancer Clinical Trials

    21 Oncology and Healthcare Policy

    22 Discovery and Characterization of Cancer Genetic Susceptibility Alleles

    23 Cancer Prevention, Screening, and Early Detection

    24 Nicotine Dependence: Current Treatments and Future Directions

    25 Surgical Interventions in Cancer

    26 Establishing and Maintaining Vascular Access

    27 Basics of Radiation Therapy

    28 Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents

    29 Cancer Pharmacology

    30 Hematopoietic Stem Cell Transplantation

    31 Gene Therapy in Oncology

    32 Therapeutic Antibodies and Immunologic Conjugates

    33 Complementary and Alternative Medicine

    Part II: Problems Common to Cancer and its Therapy

    Section A. Hematologic Problems and Infections

    34 Disorders of Blood Cell Production in Clinical Oncology

    35 Diagnosis, Treatment, and Prevention of Cancer-Associated Venous Thromboembolism

    36 Infection in the Patient with Cancer

    Section B. Metabolic and Paraneoplastic Syndromes

    37 Hypercalcemia

    38 Tumor Lysis Syndrome

    39 Paraneoplastic Neurologic Syndromes

    40 Cancer-Related Pain

    41 Cancer Cachexia

    42 Nausea and Vomiting

    43 Oral Complications

    44 Dermatologic Toxicities of Anticancer Therapy

    45 Fatigue

    46 Caring for Patients at the End of Life

    Section C. Local Effects of Cancer and Its Metastasis

    47 Acute Abdomen, Bowel/Billiary Obstruction, and Fistula

    48 Superior Vena Cava Syndrome

    49 Spinal Cord Compression

    50 Brain Metastases and Neoplastic Meningitis

    51 Bone Metastases

    52 Lung Metastases

    53 Liver Metastases

    54 Malignant Effusions

    Section D. Complications of Therapy

    55 Rehabilitation of Individuals with Cancer

    56 Survivorship

    57 Neurologic Complications

    58 Pulmonary Complications of Anticancer Treatment

    59 Cardiac Effects of Cancer Therapy

    60 Reproductive Complications

    61 Endocrine Complications

    62 Second Malignant Neoplasms

    Section E. Special Populations

    63 Cancer in the Elderly: Biology, Prevention, and Treatment

    64 Special Issues in Pregnancy

    65 Acquired Immunodeficiency Syndrome and Cancer

    Part III: Specific Malignancies

    66 Cancer of the Central Nervous System

    67 Eye, Orbit, and Adnexal Structures

    68 Cancer of the Head and Neck

    69 Melanoma

    70 Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas

    71 Cancer of the Endocrine System

    72 Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer

    73 Diseases of the Pleura and Mediastinum

    74 Cancer of the Esophagus

    75 Cancer of the Stomach and Gastroesophageal Junction

    76 Cancer of the Small Bowel

    77 Colorectal Cancer

    78 Cancer of the Rectum

    79 Cancer of the Anal Canal

    80 Liver and Bile Duct Cancer

    81 Carcinoma of the Pancreas

    82 Cancer of the Kidney

    83 Bladder Cancer

    84 Prostate Cancer

    85 Cancer of the Penis

    86 Testicular Cancer

    87 Cancers of the Cervix, Vulva, and Vagina

    88 Uterine Cancer

    89 Cancers Arising in the Ovary

    90 Gestational Trophoblastic Disease

    91 Cancer of the Breast

    92 Sarcomas of Bone

    93 Sarcomas of Soft Tissue

    94 Carcinoma of Unknown Primary

    95 Pediatric Solid Tumors

    96 Childhood Leukemia

    97 Childhood Lymphoma

    98 Acute Leukemias in Adults

    99 Myelodysplastic Syndromes

    100 Myeloproliferative Disorders

    101 Chronic Myeloid Leukemia

    102 Chronic Lymphocytic Leukemia

    103 Hairy Cell Leukemia

    104 Multiple Myeloma and Related Disorders

    105 Hodgkin Lymphoma 106

    106 Non-Hodgkin Lymphoma

    107 Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma

    108 Adult T-Cell Leukemia-Lymphoma

  • John E. Niederhuber, MD, Executive Vice President, Inova Health System; CEO and Director, Inova Comprehensive Cancer and Research Institute; CEO Inova Translational Medicine Institute, Falls Church, Virginia; Professor, Oncology and Surgery, The Johns Hopkins University School of Medicine; Deputy Director, Johns Hopkins Clinical Research Network, Baltimore, Maryland, James O. Armitage, MD, Joe Shapiro Professor of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, James H Doroshow, MD, Bethesda, Maryland, Michael B. Kastan, MD, PhD, Executive Director, Duke Cancer Institute; William W. Shingleton Professor, Pharmacology and Cancer Biology, Durham, North Carolina and Joel E. Tepper, MD, Hector MacLean Distinguished Professor of Cancer Research, Department of Radiation Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina
$349.99
$279.99
Or $0.00 with a valid access code
Not Yet Available